Yaminah2ROCKVILLE, MARYLAND, February 5, 2024 – BioHealth Innovation, Inc. (BHI), a leading public-private nonprofit organization dedicated to advancing healthcare innovation in the BioHealth Capital Region, proudly announces the appointment of Yaminah Leggett-Wells to its esteemed Board of Directors.

Yaminah Leggett-Wells serves as the Senior Director of Alliance Management at Amgen, overseeing global partnerships spanning all stages of drug development. With over 20 years of experience in the pharmaceutical industry, her expertise includes strategic leadership, clinical operations, business development, and project and alliance management.

Yaminah Leggett-Wells’ appointment to the BHI Board of Directors is a significant addition who brings valuable skills and experience to our organization,” remarked Richard Bendis, President and CEO of BHI. “Her extensive pharmaceutical industry background and commitment to our region make her an outstanding asset to our Board and our mission in the BioHealth Capital Region.”

Yaminah joined Amgen in 2023 following Amgen’s acquisition of Horizon Therapeutics. Prior to this, she played instrumental roles in the development of medicines for asthma and neuromyelitis optica spectrum disorder at AstraZeneca and Viela Bio, demonstrating her in-depth knowledge of drug development and regulatory affairs.

Yaminah holds a bachelor’s degree in chemistry from the University of Delaware, a master’s degree in Pharmacology from Howard University, and an MBA from Johns Hopkins University. She is also a certified project management professional, reflecting her dedication to excellence in her field.

“Joining the BHI Board of Directors is an honor for me, and I am excited to work with its already impressive group of leaders in the BioHealth Capital Region,” said Yaminah Leggett-Wells, Senior Director of Alliance Management at Amgen. “I look forward to working with the Board to help BHI continue growing and contributing to this industry during these critical times.”

About BioHealth Innovation, Inc.
BioHealth Innovation, Inc. (BHI) is a public-private nonprofit organization dedicated to accelerating biohealth (therapeutic, diagnostic, medtech, and health IT) commercialization in the BioHealth Capital Region (Maryland, DC, and Virginia). For more information, please visit www.BioHealthInnovation.org.

# # #

Media Contacts:
Rich Bendis
Phone: 301-637-6439
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.